Metrion Biosciences Names Montana as Non-Executive Director
10 February 2021 - - UK-based specialist ion channel contract research and drug discovery company Metrion Biosciences Ltd has appointed John Montana, PhD, as a non-executive director, the company said.

Expansion of the board of directors will support the company's further growth.

Montana brings over 30 years' drug discovery and development experience across the pharmaceutical, biotech, and contract research sectors. Dr Montana is currently operating partner at Forbion, the life science venture capital firm.

His previous roles have included Corporate vice president, Integrated Drug Discovery, at Charles River Labs, as well as multiple C-suite positions such as CSO at Argenta, CEO of Amedis, Head of Chemistry at Chiroscience, and various roles at GlaxoSmithKline.

Dr Montana holds a BSc in Chemistry from The University of Manchester and a PhD in Medicinal Chemistry from the University of East Anglia.